Authors: Jiwon Yang, Mustafa Balkaya, Cesar Beltran, Ji Hoe Heo and Sunghee Cho
Summary: Brain injury from stroke is typically considered an event exclusive to the central nervous system, but injury progression and repair processes are profoundly influenced by peripheral immunity. Stroke stimulates an acute inflammatory response that results in a massive infiltration of peripheral immune cells into the ischemic area. While these cells contribute to the development of brain injury, their recruitment has been considered as a key step for tissue repair. The paradoxical role of inflammatory monocytes in stroke raises the possibility that the manipulation of peripheral immune cells prior to infiltration into the brain could influence stroke outcome. One such manipulation is remote ischemic limb conditioning (RLC), which triggers an endogenous tolerance mechanism. We observed that mice subjected to post-stroke RLC shifted circulating monocytes to a CCR2+ pro-inflammatory monocyte subset and had reduced acute brain injury, swelling, and improved motor/gait function in chronic stroke. The RLC benefits were observed regardless of injury severity, with a greater shift to a CCR2+ subset in severe stroke. Adoptive transfer of CCR2-deficient monocytes abolished RLC-mediated protection. The study demonstrates the importance of RLC-induced shift of monocytes to a CCR2+ pro-inflammatory subset in attenuating acute injury and promoting functional recovery in chronic stroke. The defined immune-mediated mechanism underlying RLC-benefits allows for an evidence-based framework for the development of immune-based therapeutic strategies for stroke patients.
Source: Journal of Neuroscience, August 19, 2019: 2699-18